Denali Therapeutics (DNLI) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.8
-0.73
-0.66
-0.59

Details

Expected EPS
-0.696493
Actual EPS
-0.78
Surprise EPS
-0.08
Surprise Percent
+11.99%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.78 per share for Q2 2025.

0 Comments

Share your thoughts